Navigation Links
Glycos Biotechnologies, Inc. Selected to Present at Alternative Energy Innovations 2009
Date:11/13/2009

Executive Chairman to Discuss Alternative Approach to Biofuel and Chemical Production

(PRWEB) November 13, 2009 -- Glycos Biotechnologies, Inc. (GlycosBio), a metabolic engineering innovator in biologically converting non-sugar feedstocks into next generation bioproducts, today announced Rich Cilento, Executive Chairman, will be a presenter at Alternative Energy Innovations 2009 on November 17th in Redwood City, CA.

With a mission to find a better way to create biofuels and chemicals, GlycosBio has uniquely discovered a number of microorganisms that can biologically convert by-products including glycerol and free fatty acids into higher-value green chemicals. By not following the typical sugars-based fermentation research, GlycosBio has created a proprietary technology that provides the industry with an alternative approach to traditional corn or sugar-based biofuel and chemical production.

In his presentation, Cilento will discuss the industry’s need to integrate microbe and fermentation technologies into their manufacturing plans. He will provide an overview of GlycosBio’s technology and how biofuel, oleochemical, palm oil and petrochemical producers can protect themselves from the commodity risk that a single feedstock business model brings; rapidly implement a biorefinery based on their existing plant and equipment; create greater yields and increase product values.

What:    “GlycosBio Business and Technology Overview”

Who:   Rich Cilento, Executive Chairman, GlycosBio

Where:   Alternative Energy Innovations: Sofitel San Francisco Bay, Redwood City, CA

When:   Biofuels Track: Tuesday, November 17 - 11:25am and 12:10pm

About Rich Cilento
Rich Cilento has extensive leadership and technical experience with energy, biotechnology, and information technology companies. He received national business honors in 2006, winning the Ernst and Young Entrepreneur of the Year Award for Energy Technology. Cilento is currently serving as Executive Chairman of DFJ Mercury portfolio company GlycosBio. Previously, he was the Founder, President and CEO of FuelQuest, Inc. (acquired by Saracen Energy), a provider of on-demand supply chain management and tax automation software and services for suppliers, distributors, fuel buyers and traders in Global Downstream Energy.

Cilento began his career at NASA where he was a space shuttle flight controller. He and his flight control team had responsibility for redesigning NASA’s Mission Control Center and implementing NASA’s Software Management Plan.

Cilento holds a BS in Aeronautical and Astronomical Engineering from the University of Illinois, an MBA from the University of Houston and serves as an advisor to a number of small businesses in Texas.

About Glycos Biotechnologies, Inc.
Glycos Biotechnologies, Inc. (GlycosBio) is pioneering the metabolic engineering of microbial strains to consume multiple non sugar-based, low value feedstocks for the production of sustainable chemical intermediates and advanced ethanol. By creating differentiated bioprocesses, GlycosBio’s bioconversion technology can lower costs, provide a non food energy balance and price stability to the chemical and biofuel industries. GlycosBio is a Houston-based industrial biotechnology company started with technology initially developed at Rice University. For more information, visit www.glycosbio.com.

###

Read the full story at http://www.prweb.com/releases/2009/11/prweb3192574.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
2. Maven Biotechnologies, LLC to Present at BIOCOM Investor Conference
3. Millennium Biotechnologies, Inc. Launches SURGEX(TM) the First Scientifically Validated Sports Nutritional Product Created from the Medical Markets
4. Raven biotechnologies, inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies
5. Microchip Biotechnologies, Inc. Collaborating With Stanford University on Developing a Front End Microfluidic-Based Sample Preparation System for Pyrosequencing Platforms
6. Millennium Biotechnologies, Inc. Signs Marketing and Distribution Agreement with Ferring Pharmaceuticals
7. Microchip Biotechnologies, Inc. Enters Into License Arrangement With GE Healthcare for Fundamental Microfluidic Patents
8. Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc.
9. Microchip Biotechnologies, Inc. Awarded Contract Under US Army Commercialization Pilot Program
10. Solos Endoscopy, Inc. Sells Ovascope and Mastascope Product Line to Lifeline Biotechnologies, Inc.
11. TriLink BioTechnologies, Inc. Relaunches Oligonucleotide Radiolabeling Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... ... consortium of pharmaceutical and biotechnology companies dedicated to collaboratively developing improved chemistry, ... in supplying a vendor-supported, portable online UHPLC, with robust, probe-based sampling. ...
(Date:12/2/2016)... , Dec. 1, 2016   SurePure, Inc. ... today that the Company has concluded an agreement with ... for a 90-day period to acquire units of the ... approximately USD 3.7 million.  Concurrently with ... Tamarack under which Tamarack will seek regulatory approvals in ...
(Date:12/2/2016)... Dec. 2, 2016 /PRNewswire/ - bioLytical Laboratories, a world leader in rapid infectious disease ... Kenya,s Pharmaceutical Association members. (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) ... ... , , ... Kenya Pharmaceutical Association (KPA) to introduce the INSTI HIV Self Test to 350 pharmacy ...
(Date:11/30/2016)... CLEVELAND , Nov. 30, 2016  GenomOncology today announced ... Vice President of Medical Affairs.  Dr. Coleman ... enhancing the company,s proprietary knowledge-enabled platform. The GenomOncology software suite ... of genetic sequencing data and clinical decision support, from quality ... , ...
Breaking Biology Technology:
(Date:11/29/2016)... , Nov. 29, 2016 BioDirection, a privately ... products for the objective detection of concussion and other ... has successfully completed a meeting with the U.S. Food ... blood test Pre-Submission Package. During the meeting company representatives ... as a precursor to commencement of a planned pilot ...
(Date:11/29/2016)... , November 29, 2016 Nearly one billion matches ... Reading ... DERMALOG ... of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric supplier: The company's ...
(Date:11/24/2016)... Cercacor today introduced Ember TM Sport ... non-invasively measure hemoglobin, Oxygen Content, Oxygen Saturation, Perfusion ... in approximately 30 seconds. Smaller than a smartphone, using ... to key data about their bodies to help monitor ... Hemoglobin carries oxygen to muscles. When hemoglobin ...
Breaking Biology News(10 mins):